CompletedPhase 1NCT00008450

Total-Body Irradiation Followed By Cyclosporine and Mycophenolate Mofetil in Treating Patients With Severe Combined Immunodeficiency Undergoing Donor Bone Marrow Transplant

Studying Adenosine Deaminase Deficiency

Last synced from ClinicalTrials.gov May 6, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Fred Hutchinson Cancer Center
Principal Investigator: Lauri Burroughs
Fred Hutch/University of Washington Cancer Consortium
Intervention: Allogeneic Bone Marrow Transplantation(procedure)
Enrollment: 6 enrolled
Eligibility: All sexes
Timeline: 1997 – 2018

Study locations (1)

Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States

Collaborators

National Cancer Institute (NCI) · National Heart, Lung, and Blood Institute (NHLBI)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00008450 on ClinicalTrials.gov

Other trials for Adenosine Deaminase Deficiency

Additional recruiting or active studies for the same condition.

ENROLLING BY INVITATIONNCT04049084
An Observational LTFU Study for Patients Previously Treated With Autologous ex Vivo Gene Therapy for ADA-SCID
University of California, Los Angeles

See all trials for Adenosine Deaminase Deficiency →

← Back to all trials